Scientific program 2017
View pdf program here  
   
| 
 Thursday March 23  | 
||||
| 09.30 | Welcoming coffee | |||
| 10.00 | Trials and Update on EVAS Chairman: Ian Loftus Moderator: Jean-Paul de Vries  | 
|||
| 10.00 10.25 10.40  | 
- Understanding how to personalize AAA care. Lessons from history, Bob Mitchell - Global registry results and lessons from comparison with US IDE trial, Andrew Holden - IRENE- outcomes from the Italian Registry, Michelangelo Ferri  | 
|||
| 11.00 | Imaging Chairman: Michel Reijnen Moderator: Paul Hayes  | 
|||
| 11.00 11.15 11.30 11.45 12.00  | 
- How to survey EVAS, Richard McWilliams - EVAS surveillance using custom software, Jean-Paul de Vries - MRI in assessment of EVAS, Bruno Gossetti - Flow dynamics following EVAS, Michel Reijnen - The effect of seal zone on outcomes following EVAS, Janis Savlovskis  | 
|||
| 12.15 | Finger buffet lunch | |||
| 13.15 | Clinical Practice Chairman: Matt Thompson Moderator: Andrew Hill  | 
|||
| 13.15 13.30 13.45 14.00 14.15 14.30 14.45  | 
- Contrast use and radiation EVAS versus EVAR, Andreas Peters OBO / Dittmar Böckler - How to select patients for EVAS, Jorg De Bruin - My learning curve with Nellix , Sven Ross Mathisen - Nellix inside and outside IFU: implications for practice , Jan Heyligers - Pressure modification in the renal arteries after EVAS; implication for renal function , Jean-Marc Alsac - How to manage aneurysmatic iliac, Dainis Krievins - How to manage Nellix stent thrombosis , Paul Hayes  | 
|||
| 15.00 | Thrombus Behaviour Pre and Post-EVAS Chairman: Pierre Julia Moderator: Ian Loftus  | 
|||
| 15.00 15.15 15.30  | 
- Thrombus behaviour pre and post-Nellix, Jean-Paul de Vries - Post-implantation syndrome after EVAS and EVAR, Patrick Berg - SIRS after EVAS and EVAR, Kate Stenson  | 
|||
| 15.45 | Tea / coffee break | |||
| 16.15 | Clinical Engineering Session – Migration Chairman: Andrew Holden Moderator: Sven Ross Mathisen  | 
|||
| 16.15 16.30 16.45 17.00  | 
- Migration of Nellix: the Liverpool experience, Francesco Torella - Fixation in the proximal neck: implications for migration, Jean-Marc Alsac - Engineering talk, Peter Costandi - Recommendation regarding the treatment of Nellix migration, Matt Thompson  | 
|||
| 17.15 | Discussion Forum | 
|||
| 17.30 | End of the sessions | |||
| 19.00 | SAS Official dinner MASSIS RESTAURANT 9 Sheldon Square Paddington Central London W2 6HY  | 
|||
  
| 
 Friday March 24  | 
||||
| 08.00 | Welcoming coffee | |||
| 08.30 | Late Breaking News: Nellix migration and the IDE Results. Insights in artiology and therapy. Chairman: Matt Thompson Moderator: Andrew Holden  | 
|||
| 09.00 | Case Discussions Chairman: Eric Zimmerman Moderator: Ian Loftus  | 
|||
| 10.00 | Tea / coffee break | |||
| 10.30 | Clinical-Engineering Session – Endoleaks after EVAS Chairman: Jean-Paul de Vries Moderator: Peter Holt  | 
|||
| 10.30 10.45 11.00 11.15 11.30  | 
- The aetiology and management of type 1A endoleaks after EVAS, Michel Reijnen - How I treat type 1A endoleaks (including Nellix in Nellix), Sebastian Zerwes - Type 2 endoleaks and EVAS, Peter Costandi - No more EVAR!! - the importance of EVAS from our long-term data of type 2, Toru Kuratani - Should an EVAR or EVAS device seal in neck thrombus? Boonprasit Kritpracha  | 
|||
| 11.45 | Ch-EVAS Chairman: Hence Verhagen Moderator: Francesco Torella  | 
|||
| 11.45 12.00 12.15 12.30 12.45 13.00  | 
- In vitro experiments and implications for Ch-EVAS, Jorn P. Meekel OBO / Jan Blankensteijn - Engineering aspects of Ch-EVAS, Peter Costandi - Geometry of Ch-EVAS in vivo and in vitro, Michel Reijnen - The impact of cardiac and respiratory motion on branch stents in Ch-EVAS, Andrew Holden - ASCEND registry, Matt Thompson - How I do Ch-EVAS, Peter Holt  | 
|||
| 13.15 | Finger buffet lunch | |||
| 14.15 | Treatment of The Iliac System Chairman: Andrew Hill Moderator: Michelangelo Ferri  | 
|||
| 14.15 14.30  | 
- Nellix EVAS in iliac artery disease; methods to preserve the internal iliac artery,  Andrew Holden - Multi-center experience of EVAS for iliac aneurysms, Jean-Paul de Vries  | 
|||
| 14.45 | Expanded Indications Chairman: Andrew Hill Moderator: Piotr Szopinski  | 
|||
| 14.45 15.00 15.15  | 
- EVAS in EVAR, Marwan Youssef - Distraction forces after EVAS implications for EVAR repair, Francesco Torella - Nellix outside of traditional indications, Piotr Szopinski  | 
|||
| 15.30 | State of Nellix lecture, Andrew Holden | |||
| 16.00 | Adjournment | |||